543 related articles for article (PubMed ID: 9682799)
21. [Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis].
Ribot C; Tremollieres F; Pouilles JM
Ann Med Interne (Paris); 2000 Oct; 151(6):490-6. PubMed ID: 11104929
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy: estrogen after menopause.
Gibaldi M
Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
[No Abstract] [Full Text] [Related]
23. [Patients' and population's knowledge of osteoporosis].
Ryg J; Nissen N; Nielsen D; Brixen KT
Ugeskr Laeger; 2005 Jan; 167(3):282-5. PubMed ID: 15704797
[No Abstract] [Full Text] [Related]
24. [Prevention of osteoporosis--why? Who? How?].
Siggelkow H; Hüfner M
Med Klin (Munich); 1995 Nov; 90(11):639-44. PubMed ID: 8569632
[No Abstract] [Full Text] [Related]
25. Prevention of osteoporotic hip fracture: global versus high-risk strategies.
Barrett-Connor E; Gore R; Browner WS; Cummings SR
Osteoporos Int; 1998; 8 Suppl 1():S2-7. PubMed ID: 9682789
[No Abstract] [Full Text] [Related]
26. [Estrogens and prevention of postmenopausal osteoporosis].
Chaouat D
Ann Med Interne (Paris); 1996; 147(6):432-40. PubMed ID: 9092346
[No Abstract] [Full Text] [Related]
27. Individualizing hormone-therapy according to cardiovascular risk.
Shoupe D
Minerva Med; 2012 Oct; 103(5):343-52. PubMed ID: 23042369
[TBL] [Abstract][Full Text] [Related]
28. [Estrogens for treatment of osteoporoses].
Higuchi T; Tarakida A; Abe K; Mizunuma H
Nihon Rinsho; 2009 May; 67(5):954-9. PubMed ID: 19432116
[TBL] [Abstract][Full Text] [Related]
29. Osteoporosis: prevention is key to management.
Levin RM
Geriatrics; 1993 Jun; 48 Suppl 1():18-24. PubMed ID: 8508962
[TBL] [Abstract][Full Text] [Related]
30. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
Seeman E; Eisman JA
Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
[TBL] [Abstract][Full Text] [Related]
31. [Hormone replacement therapy: the pros].
Jamin C; Madelenat P
Gynecol Obstet Fertil; 2008 Jan; 36(1):98-103. PubMed ID: 18248839
[No Abstract] [Full Text] [Related]
32. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
Col NF; Bowlby LA; McGarry K
Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
[TBL] [Abstract][Full Text] [Related]
33. Update: the latest on hormone replacement therapy.
Packin GS
J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S2-5. PubMed ID: 11105456
[TBL] [Abstract][Full Text] [Related]
34. The waning effect of postmenopausal estrogen therapy on osteoporosis.
Ettinger B; Grady D
N Engl J Med; 1993 Oct; 329(16):1192-3. PubMed ID: 8377785
[No Abstract] [Full Text] [Related]
35. [What is reliable in the treatment of osteoporosis in menopausal women?].
Ziegler R
Internist (Berl); 1993 Jan; 34(1):18-24. PubMed ID: 8440570
[No Abstract] [Full Text] [Related]
36. [Drug therapy of osteoporosis].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2263-4. PubMed ID: 14508549
[No Abstract] [Full Text] [Related]
37. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Shulman LP
J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
[No Abstract] [Full Text] [Related]
38. [Prevention of osteoporosis and its economic aspects].
Blachier C
Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
[TBL] [Abstract][Full Text] [Related]
39. Current perspective in the management of menopausal and postmenopausal women.
Dumesic DA
J Clin Pharmacol; 1992 Sep; 32(9):774-8. PubMed ID: 1331204
[No Abstract] [Full Text] [Related]
40. Menopause and osteoporosis: the role of HRT.
Carson DS
J Am Pharm Assoc (Wash); 1996 Apr; NS36(4):234-242, 269. PubMed ID: 8919598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
